跳至主要内容
临床试验/CTRI/2023/02/050063
CTRI/2023/02/050063已完成4 期

A clinical study to evaluate the efficacy and safety of the test product verses placebo in improvement of skin appearance in healthy human Volunteers.

ZeusHygia Life sciences Pvt Ltd0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Healthy female subjects in the age group of 35-65 years (both age inclusive)
  • 2. Female subjects with dark spots, pimple marks and facial pigmentation
  • 3. Subjects with skin phototype IV to VI
  • 4. Females subjects with a stable hormonal status and related endocrine diseases, as
  • self-declared by subjects.
  • 5. Subjects with minimum grade 2 of crow’s feet wrinkles as per Skin aging atlas, volume
  • IV Indian skin type, by BAZIN & FLAMENT
  • 6. Subjects willing to give a voluntary written informed consent and comply with
  • the requirement of the study.

排除标准

  • 1.Known hypersensitivity to any of the study products or constituents or cosmetics
  • 2. Any significant skin pathology in the test area (face)
  • 3. Currently taking any medication including food supplements, which the Investigator
  • believes may influence the interpretation of the data
  • 4. Having chronic illness or had major surgery in the last year.
  • 5. Subjects having any significant ophthalmic illness or have undergone eye surgery in the
  • past 6 months
  • 6. Subjects who has got nose piercing/ facial piercing in past 6 months
  • 7. Subjects with active/ inflamed pimple or any active lesion on the face
  • 8. Undergoing any treatment of any skin condition on their face/body
  • 9. Allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery, or
  • anything else

研究者

发起方
ZeusHygia Life sciences Pvt Ltd

相似试验